B

Bicara Therapeutics Inc
NASDAQ:BCAX

Watchlist Manager
Bicara Therapeutics Inc
NASDAQ:BCAX
Watchlist
Price: 9.32 USD -1.17% Market Closed
Market Cap: 508.3m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

BCAX Price Targets Summary
Bicara Therapeutics Inc

Wall Street analysts forecast BCAX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BCAX is 33.25 USD with a low forecast of 8.08 USD and a high forecast of 50.4 USD.

BCAX Lowest Forecast
Wall Street Target
8.08 USD
13% Downside
BCAX Average Forecast
Wall Street Target
33.25 USD
257% Upside
BCAX Highest Forecast
Wall Street Target
50.4 USD
441% Upside
Lowest
Price Target
8.08 USD
13% Downside
Average
Price Target
33.25 USD
257% Upside
Highest
Price Target
50.4 USD
441% Upside
Bicara Therapeutics Inc Competitors:
Price Targets
688428
InnoCare Pharma Ltd
1% Downside
STTK
Shattuck Labs Inc
162% Upside
IMMX
Immix Biopharma Inc
219% Upside
VRTX
Vertex Pharmaceuticals Inc
17% Upside
688428
InnoCare Pharma Ltd
1% Downside
STTK
Shattuck Labs Inc
162% Upside
IMMX
Immix Biopharma Inc
219% Upside
VRTX
Vertex Pharmaceuticals Inc
17% Upside
EXAS
Exact Sciences Corp
33% Upside
TRDA
Entrada Therapeutics Inc
194% Upside
MNKD
MannKind Corp
155% Upside
P
000403
Pacific Shuanglin Bio pharmacy Co Ltd
18% Upside

Revenue
Forecast

Revenue Estimate
Bicara Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Bicara Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Bicara Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
BCAX intrinsic value, competitors valuation, and company profile.
DCF Valuation
BCAX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BCAX stock valuation using valuation multiples.
Wall Street Estimates
BCAX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BCAX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BCAX's stock price target?
Price Target
33.25 USD

According to Wall Street analysts, the average 1-year price target for BCAX is 33.25 USD with a low forecast of 8.08 USD and a high forecast of 50.4 USD.

Back to Top
ALPHA SPREAD
Follow us
Join more than 263,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.